Avita Medical | Bruttoergebnis Vom Umsatz

Aktienkurs
1.09
Täglich Wechseln
-0.05 -3.96%
Monatlich
4.31%
Jährlich
-62.67%
Q1 Prognose
1.06




Bruttoergebnis Vom Umsatz Veränderung Datum
Celltrion KRW 626.11B 81.75B 2025-09
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 426.8M 454.9M 2025-06
CSL USD 1.75B 2.53B 2025-06
Cspc Pharmaceutical CNY 4.34B 333.68M 2025-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 14.54B 1.5B 2025-06
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 44.83M 9.96M 2025-06
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Mayne Pharma AUD 86.13M 18.92M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Nanosonics AUD 81.96M 8.51M 2025-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 31.84M 23.88M 2025-09
Pacific Edge NZD 5.2M 1.75M 2024-06
Paradigm Biopharmaceuticals AUD -9K 423.94K 2025-06
Pharma Mar EUR 33.36M 20.25M 2025-09
Polynovo AUD 23.26M 22.74M 2024-06
PYC Therapeutics AUD 5.83M 750K 2025-06
Qiagen NV USD 344.8M 10.51M 2025-09
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 886.53M 65.71M 2025-12
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Telix Pharmaceuticals AUD 129.12M 96.58M 2024-12
Tilray USD 67.63M 15.62M 2025-03
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06


Avita Medical Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.